Alpa Laboratories Limited (NSE:ALPA)
96.25
+0.16 (0.17%)
Aug 8, 2025, 3:29 PM IST
Alpa Laboratories Revenue
In the fiscal year ending March 31, 2025, Alpa Laboratories had annual revenue of 1.12B INR with 3.41% growth. Alpa Laboratories had revenue of 399.19M in the quarter ending March 31, 2025, with 69.10% growth.
Revenue
1.12B
Revenue Growth
+3.41%
P/S Ratio
1.80
Revenue / Employee
2.74M
Employees
410
Market Cap
2.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
Mar 31, 2021 | 975.54M | 115.85M | 13.48% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 80.96B |
Aurobindo Pharma | 320.25B |